AR052155A1 - Compuestos organicos - Google Patents

Compuestos organicos

Info

Publication number
AR052155A1
AR052155A1 ARP050105195A ARP050105195A AR052155A1 AR 052155 A1 AR052155 A1 AR 052155A1 AR P050105195 A ARP050105195 A AR P050105195A AR P050105195 A ARP050105195 A AR P050105195A AR 052155 A1 AR052155 A1 AR 052155A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
water
insoluble
animal
human
Prior art date
Application number
ARP050105195A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR052155A1 publication Critical patent/AR052155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP050105195A 2004-12-14 2005-12-12 Compuestos organicos AR052155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14

Publications (1)

Publication Number Publication Date
AR052155A1 true AR052155A1 (es) 2007-03-07

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105195A AR052155A1 (es) 2004-12-14 2005-12-12 Compuestos organicos

Country Status (16)

Country Link
JP (1) JP5372378B2 (pt)
KR (1) KR101304160B1 (pt)
CN (1) CN101056617B (pt)
AR (1) AR052155A1 (pt)
AT (1) ATE389386T1 (pt)
AU (1) AU2005315823B2 (pt)
BR (1) BRPI0519022A2 (pt)
CA (1) CA2585779C (pt)
DE (1) DE602005005522T2 (pt)
ES (1) ES2301084T3 (pt)
MX (1) MX2007007099A (pt)
NZ (1) NZ554904A (pt)
RU (1) RU2394558C2 (pt)
TW (1) TWI369218B (pt)
WO (1) WO2006063794A1 (pt)
ZA (1) ZA200703506B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
EP3609470B1 (en) 2017-04-13 2023-11-22 Ceva Santé Animale Implant for treating parasites infestations
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
CA2591581C (en) * 1996-12-20 2013-01-29 Alza Corporation Gel composition and methods
SI1063942T1 (en) * 1998-03-19 2004-10-31 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
BR0315304A (pt) * 2002-11-06 2005-08-16 Alza Corp Formulações com depósito para liberação controlada
JP2007525429A (ja) * 2003-03-11 2007-09-06 キューエルティー ユーエスエー，インコーポレイテッド． 細胞スケジュール依存性抗癌剤のための処方

Also Published As

Publication number Publication date
CA2585779C (en) 2014-01-28
CA2585779A1 (en) 2006-06-22
JP2008523131A (ja) 2008-07-03
WO2006063794A1 (en) 2006-06-22
CN101056617A (zh) 2007-10-17
MX2007007099A (es) 2007-06-22
DE602005005522T2 (de) 2009-04-16
AU2005315823B2 (en) 2009-06-04
KR20070092964A (ko) 2007-09-14
JP5372378B2 (ja) 2013-12-18
RU2007126759A (ru) 2009-01-27
TW200635616A (en) 2006-10-16
CN101056617B (zh) 2012-07-11
DE602005005522D1 (de) 2008-04-30
ZA200703506B (en) 2008-09-25
KR101304160B1 (ko) 2013-09-04
BRPI0519022A2 (pt) 2008-12-23
AU2005315823A1 (en) 2006-06-22
NZ554904A (en) 2009-11-27
RU2394558C2 (ru) 2010-07-20
ES2301084T3 (es) 2008-06-16
ATE389386T1 (de) 2008-04-15
TWI369218B (en) 2012-08-01

Similar Documents

Publication Publication Date Title
AR052155A1 (es) Compuestos organicos
Narayanaswamy et al. Hydrogels and their applications in targeted drug delivery
CA2273017C (fr) Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parenterale et procede de preparation
CA2623561C (en) Gelling hydrophobic injectable polymer compositions
JP5628467B2 (ja) 生体分解性徐放性ドラッグデリバリーシステム
ES2116308T5 (es) Procedimiento para la produccion de un dispositivo implantable a base de un material polimero, que contiene principios activos farmaceuticos.
CA2468703A1 (en) Controlled release polymeric compositions of bone growth promoting compounds
Lin et al. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract
WO2006041942A3 (en) Ocular delivery of polymeric delivery formulations
NZ597621A (en) Sustained delivery formulations of risperidone compounds
HRP20211853T1 (hr) Sastavi in situ injekcijskih biorazgradivih implantata
DE60209446D1 (de) Medizinische Implantatvorrichtung , Einführgerät und Implantierungsverfahren für ein Wirkstoff und Zellen enthaltendes Implantat
DK1660034T3 (da) Fremstilling af langtidsafgivende medikamentindretninger af polyurethanbaserede polymerer
JP2017522365A (ja) 薬物送達システム及び関連する使用方法
RU2463079C2 (ru) Разделительные агенты для имплантируемого устройства и способы их применения
ATE332125T1 (de) Emulsionen für in-situ arzneistoffabgabesysteme
CN106102751A (zh) 用吉西他滨来治疗膀胱癌的药物递送系统和方法
RU2015109296A (ru) Системы доставки лекарственного средства и способы лечения рака мочевого пузыря, включающие применение оксалиплатина
CN111132670A (zh) 具有增强的渗透的药物组合物
AR118753A1 (es) Método de tratamiento de un niño con pubertad precoz central usando una composición de liberación prolongada
AR078165A1 (es) Adhesivo de hidrogel para protesis dentales, su preparacion
CN102274560B (zh) 注射针
CN104208711A (zh) 壳聚糖半流体缓释凝胶及用途

Legal Events

Date Code Title Description
FB Suspension of granting procedure